Persistent Cytopenias after Chimeric Antigen Receptor T-Cell Immunotherapy for CD19+ Aggressive Lymphoma: A Single Institution Experience

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2019
EventTransplant & Cellular Therapy Meetings of ASBMT and CIBMTR - Houston, TX
Duration: Jan 1 2019 → …

Conference

ConferenceTransplant & Cellular Therapy Meetings of ASBMT and CIBMTR
Period1/1/19 → …

Disciplines

  • Medicine and Health Sciences

Cite this